Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $91 which represents a slight increase of $1.06 or 1.18% from the prior close of $89.94. The stock opened at $90.59 and touched ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Stephen King has a slew of new books coming out in the next few years, but long-teased sequel he finally confirmed is the ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Aria Aber’s debut about an Afghan German party girl in Berlin shows that there are plenty of ways to tell an outsider’s story ...

In “Open Socrates,” the scholar Agnes Callard argues that the ancient Greek philosopher offers a blueprint for an ethical ...

There’s more than one ghost in the machine in,” Nnedi Okorafor’s new sci-fi-adjacent novel finely attuned to our age of AI ...

The "Antibody Drug Conjugates Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering.World revenue for the Antibody Drug Conjugates Market is set to surpass US$16 billion in 2025 ...

Neil Gaiman, the bestselling fantasy author, denied sexual abuse allegations made by eight women in an explosive New York ...

Author Neil Gaiman denied allegations of sexual assault and abuse made by multiple women and reported in a New York Magazine story earlier this week.